Screener
Zevra Therapeutics, Inc. ZVRA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use assets | $1,667 | $1,212 |
| Current portion of operating lease liabilities | $626 | $419 |
| Operating lease liabilities, less current portion | 870 | 859 |
| Total operating lease liabilities | $1,496 | $1,278 |
| Weighted average remaining lease term | 2.2 | 3.0 |
| Weighted average discount rate | 14.3% | 13.0% |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s operating lease ROU assets?
- Zevra Therapeutics, Inc. (ZVRA) reported operating lease ROU assets of 14.3% in Q2 2026.
- How has Zevra Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Zevra Therapeutics, Inc.'s operating lease ROU assets increased by 13.5% year-over-year, from 12.6% to 14.3%.
- What is the long-term trend for Zevra Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s operating lease ROU assets has grown at a -96.0% compound annual growth rate (CAGR), from 135,000,000% to 13%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Zevra Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude